Atlas Trials

Evaluation of Efficacy and Safety De-escalation Versus Standard Adjuvant Chemotherapy in Patients With Low Risk Localized Gastroesophageal Adenocarcinoma

Clinical trial NCT06933966 · NOT_YET_RECRUITING

Trial details

NCT number
NCT06933966
Sponsor
Centre Leon Berard
Status
NOT_YET_RECRUITING
Phase
Phase 2
Study type
INTERVENTIONAL
Gastric Adenocarcinoma or Gastroesophageal Junction Adenocarcinoma or Esophageal CarcinomaNon Metastatic Disease
Start date
2025-09-01
Primary completion
2030-09-01
Enrollment
120

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.